Callan JMB Inc. (CJMB)
NASDAQ: CJMB · Real-Time Price · USD
0.760
-0.010 (-1.30%)
At close: Jun 26, 2026, 4:00 PM EDT
0.805
+0.045 (5.91%)
After-hours: Jun 26, 2026, 7:47 PM EDT

Company Description

Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States.

It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities.

The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; specialty temperature-regulating packaging; technical services; and advanced monitoring sentry technology.

The company was founded in 2006 and is headquartered in Spring Branch, Texas.

Callan JMB Inc.
Callan JMB logo
Country United States
Founded 2007
IPO Date Feb 5, 2025
Industry Integrated Freight & Logistics
Sector Industrials
Employees 20
CEO Wayne Williams

Contact Details

Address:
244 Flightline Drive
Spring Branch, Texas 78070-6241
United States
Phone 830 438 0395
Website callanjmb.com

Stock Details

Ticker Symbol CJMB
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.00
CIK Code 0002032545
CUSIP Number 131100109
ISIN Number US1311001093
Employer ID 99-0931141
SIC Code 7389

Key Executives

Name Position
Wayne Williams Founder, Chief Executive Officer, President and Chairman
Christopher Shields Interim Chief Financial Officer and Senior Vice President of Governmental Affairs and Chief Operating Officer

Latest SEC Filings

Date Type Title
Jun 11, 2026 8-K Current Report
Jun 5, 2026 EFFECT Notice of Effectiveness
May 27, 2026 8-K Current Report
May 26, 2026 S-3 Registration statement under Securities Act of 1933
May 26, 2026 S-8 Securities to be offered to employees in employee benefit plans
May 15, 2026 10-Q Quarterly Report
May 13, 2026 SCHEDULE 13G/A Filing
Apr 10, 2026 8-K Current Report
Mar 31, 2026 10-K Annual Report
Mar 31, 2026 8-K Current Report